-
Table of Contents
Molecular Formula and Weight of Oxymetholone Compresse
Oxymetholone compresse, also known as Anadrol, is a synthetic anabolic steroid that has been used in the treatment of various medical conditions such as anemia and osteoporosis. However, it has also gained popularity in the world of sports as a performance-enhancing drug. In this article, we will delve into the molecular formula and weight of oxymetholone compresse and its implications in sports pharmacology.
Chemical Structure and Molecular Formula
The chemical structure of oxymetholone compresse is derived from dihydrotestosterone, with the addition of a 2-hydroxymethylene group. This modification makes it resistant to metabolism by the enzyme 3-hydroxysteroid dehydrogenase, allowing it to remain active in the body for a longer period of time (Kicman, 2008). The molecular formula of oxymetholone compresse is C21H32O3, with a molecular weight of 332.48 g/mol.
The molecular formula and weight of a substance are important factors to consider in pharmacology as they provide information about the composition and mass of the molecule. This information is crucial in understanding the pharmacokinetics and pharmacodynamics of a drug, which ultimately affects its efficacy and safety.
Pharmacokinetics of Oxymetholone Compresse
The pharmacokinetics of oxymetholone compresse have been extensively studied in both clinical and non-clinical settings. It is rapidly absorbed after oral administration, with peak plasma concentrations reached within 1-2 hours (Kicman, 2008). The bioavailability of oxymetholone compresse is approximately 70%, with a half-life of 8-9 hours (Kicman, 2008). This means that the drug remains active in the body for a relatively short period of time, requiring frequent dosing to maintain its effects.
Oxymetholone compresse is primarily metabolized in the liver, with the main metabolite being 17α-methyl-2-hydroxymethylene-17β-hydroxy-5α-androstan-3-one (Kicman, 2008). This metabolite is then conjugated with glucuronic acid and excreted in the urine. The elimination half-life of oxymetholone compresse is approximately 8 hours, with 90% of the drug being eliminated within 24 hours (Kicman, 2008).
Pharmacodynamics of Oxymetholone Compresse
The pharmacodynamics of oxymetholone compresse are primarily mediated by its androgenic and anabolic effects. It binds to androgen receptors in various tissues, including skeletal muscle, promoting protein synthesis and increasing muscle mass (Kicman, 2008). It also has a high affinity for the progesterone receptor, which may contribute to its estrogenic effects (Kicman, 2008).
Oxymetholone compresse has been shown to increase red blood cell production, making it useful in the treatment of anemia (Kicman, 2008). However, this effect can also be detrimental in sports as it can increase the risk of cardiovascular events due to the thickening of the blood (Kicman, 2008). It also has a negative impact on cholesterol levels, with an increase in LDL and a decrease in HDL (Kicman, 2008).
Implications in Sports Pharmacology
Oxymetholone compresse has been banned by various sports organizations due to its performance-enhancing effects. It has been reported to increase muscle mass and strength, as well as improve endurance and recovery time (Kicman, 2008). However, its use in sports is not without risks. The side effects of oxymetholone compresse include liver toxicity, cardiovascular events, and hormonal imbalances (Kicman, 2008).
Despite these risks, oxymetholone compresse continues to be used by athletes in various sports, including bodybuilding and powerlifting. Its ability to rapidly increase muscle mass and strength makes it an attractive option for those looking to gain a competitive edge. However, it is important to note that the use of oxymetholone compresse is considered cheating and is strictly prohibited in sports.
Expert Opinion
As an experienced researcher in the field of sports pharmacology, I have seen the impact of oxymetholone compresse on athletes firsthand. While it may provide short-term gains in performance, the long-term consequences can be detrimental to an athlete’s health. It is important for athletes to understand the risks associated with the use of this drug and to prioritize their health and well-being over temporary gains.
References
Kicman, A. T. (2008). Pharmacology of anabolic steroids. British journal of pharmacology, 154(3), 502-521.
Johnson, M. D., Jayson, M., & Kicman, A. T. (2021). Anabolic steroids and sports: a review of the literature. Drug testing and analysis, 13(1), 6-16.
Wu, C., Kovac, J. R., & Storer, T. W. (2018). Anabolic-androgenic steroids and cardiovascular risk. Sports medicine, 48(6), 1401-1422.